December 9, 2010

HELIX BIOPHARMA REPORTS ON 2010 ANNUAL GENERAL AND SPECIAL MEETING (PDF)

AURORA, Ontario, December 9, 2010 – Helix BioPharma Corp. (TSX, NYSE Amex, FSE: “HBP”), a biopharmaceutical company
developing drug candidates for the prevention and treatment of cancer, reports that at its Annual General and Special Meeting held today, shareholders approved all of management’s proposals.